Table 1.
EAD 11 (n = 12) | Non-EAD 11 (n = 39) | p-Value | |
---|---|---|---|
Height (m) | 1.63 ± 0.09 | 1.63 ± 0.08 | 0.99 |
Weight (kg) | 66.43 ± 13.47 | 67.63 ± 11.66 | 0.78 |
BMI 1 | 24.92 ± 13.47 | 25.31 ± 3.44 | 0.74 |
Age (years) | 56.42 ± 10.82 | 56.00 ± 7.30 | 0.88 |
Gender (M/F) | 0.74 | ||
M | 8 | 22 | |
F | 4 | 17 | |
Blood type | |||
A | 5 | 15 | 1.00 |
B | 2 | 7 | |
O | 5 | 15 | |
AB | 0 | 2 | |
MELD 2 | 19.92 ± 11.89 | 16.69 ± 0.09 | 0.29 |
HBV 3 (Yes/No) | 6/6 | 18/21 | 0.82 |
HCV 4 (Yes/No) | 3/9 | 12/27 | 1.00 |
Alcoholism (Yes/No) | 4/8 | 12/2 | 1.00 |
ABO incompatibility (Yes/No) | 2/10 | 6/33 | 1.00 |
CKD 5 (Yes/No) | 5/7 | 5/34 | 0.04 |
Graft (g) | 615.00 ± 122.21 | 644.36 ± 146.22 | 0.53 |
GRWR 6 (%) | 0.96 ± 0.13 | 0.98 ± 0.30 | 0.82 |
Blood loss (mL) PRBC 7 (U) FFP 8 (U) Platelet (U) |
2962.50 ± 2111.13 | 1705.64 ± 166348 | 0.04 |
13.42 ± 8.97 | 7.90 ± 7.52 | 0.04 | |
13.83 ± 11.07 | 11.69 ± 11.05 | 0.56 | |
12.00 ± 8.86 | 8.62 ± 9.52 | 0.28 | |
CIT 9 (minutes) | 41.50 ± 37.48 | 52.97 ± 34.94 | 0.33 |
WIT 10 (minutes) | 37.08 ± 7.83 | 42.31 ± 10.94 | |
In hospital mortality (Yes/No) | 4/8 | 2/37 | 0.13 |
Hospital stay ≥45 days (Yes/No) | 9/3 | 12/27 |
1 body mass index; 2 model for end-stage liver disease; 3 hepatitis B virus; 4 hepatitis C virus; 5 chronic kidney disease; 6 graft recipient weight ratio; 7 packed red blood cell; 8 fresh frozen plasma; 9 cold ischemia time; 10 warm ischemia time; 11 early allograft dysfunction.